WO2011018496A3 - Method for modifying and functionalizing saccharides - Google Patents

Method for modifying and functionalizing saccharides Download PDF

Info

Publication number
WO2011018496A3
WO2011018496A3 PCT/EP2010/061742 EP2010061742W WO2011018496A3 WO 2011018496 A3 WO2011018496 A3 WO 2011018496A3 EP 2010061742 W EP2010061742 W EP 2010061742W WO 2011018496 A3 WO2011018496 A3 WO 2011018496A3
Authority
WO
WIPO (PCT)
Prior art keywords
saccharides
functionalizing
modifying
activating
carboxyl groups
Prior art date
Application number
PCT/EP2010/061742
Other languages
German (de)
French (fr)
Other versions
WO2011018496A2 (en
Inventor
Mikhail Tsurkan
Uwe Freudenberg
Carsten Werner
Original Assignee
Leibniz-Institut für Polymerforschung Dresden e. V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leibniz-Institut für Polymerforschung Dresden e. V. filed Critical Leibniz-Institut für Polymerforschung Dresden e. V.
Priority to EP10741975A priority Critical patent/EP2464669A2/en
Publication of WO2011018496A2 publication Critical patent/WO2011018496A2/en
Publication of WO2011018496A3 publication Critical patent/WO2011018496A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0081Reaction with amino acids, peptides, or proteins

Abstract

The invention relates to a method for modifying and functionalizing saccharides, comprising the process steps: a) activating the carboxyl groups of the saccharides by a primarily reacting each of the carboxyl groups with a carbodiimide or a triazole as an activating reagent, and subsequently reacting with N-hydroxysuccinimide (NHS) or one of the derivatives thereof, b) reacting the activating carboxyl groups with primary amino groups of amine-functionalized, optically or biologically active molecules, forming an amide bond.
PCT/EP2010/061742 2009-08-13 2010-08-12 Method for modifying and functionalizing saccharides WO2011018496A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP10741975A EP2464669A2 (en) 2009-08-13 2010-08-12 Method for modifying and functionalizing saccharides

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102009028526A DE102009028526A1 (en) 2009-08-13 2009-08-13 Process for the modification and functionalization of saccharides
DE102009028526.1 2009-08-13

Publications (2)

Publication Number Publication Date
WO2011018496A2 WO2011018496A2 (en) 2011-02-17
WO2011018496A3 true WO2011018496A3 (en) 2011-05-19

Family

ID=43495136

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2010/061742 WO2011018496A2 (en) 2009-08-13 2010-08-12 Method for modifying and functionalizing saccharides

Country Status (3)

Country Link
EP (1) EP2464669A2 (en)
DE (1) DE102009028526A1 (en)
WO (1) WO2011018496A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2101821T3 (en) 2006-12-15 2014-10-06 Baxter Healthcare Sa Factor VIIA (poly) sialic acid conjugate with extended half-life in vivo
TWI537006B (en) 2009-07-27 2016-06-11 巴克斯歐塔公司 Blood coagulation protein conjugates
RU2533619C2 (en) 2009-07-27 2014-11-20 Лайпоксен Текнолоджиз Лимитед Glycopolysialylation of proteins, which are not blood clotting proteins
US8809501B2 (en) 2009-07-27 2014-08-19 Baxter International Inc. Nucleophilic catalysts for oxime linkage
PT2459224T (en) 2009-07-27 2016-09-05 Baxalta Inc Blood coagulation protein conjugates
US8642737B2 (en) 2010-07-26 2014-02-04 Baxter International Inc. Nucleophilic catalysts for oxime linkage
CA2822591C (en) 2010-12-22 2020-12-29 Baxter International Inc. Materials and methods for conjugating a water soluble fatty acid derivative to a protein

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008081463A2 (en) * 2007-01-04 2008-07-10 Hepacore Ltd. Water soluble reactive derivatives of carboxy polysaccharides and fibrinogen conjugates thereof
WO2009005258A2 (en) * 2007-06-29 2009-01-08 Mediplex Corp. Heparin conjugates and methods
EP2030624A1 (en) * 2007-08-28 2009-03-04 Johannes Gutenberg Universität Antioxidant and paramagnetic heparin-nitroxide derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6174999B1 (en) * 1987-09-18 2001-01-16 Genzyme Corporation Water insoluble derivatives of polyanionic polysaccharides
EP1928918B1 (en) * 2005-09-27 2011-11-16 UNIVERSITE JOSEPH FOURIER - Grenoble 1 Hydrogel functionalized with a polymerizable moiety and their uses as biosensors or bioreactors
CN101367884A (en) * 2008-09-25 2009-02-18 复旦大学 Cysteamine modified sulfhydryl hyaluronic acid couplet, preparation and application thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008081463A2 (en) * 2007-01-04 2008-07-10 Hepacore Ltd. Water soluble reactive derivatives of carboxy polysaccharides and fibrinogen conjugates thereof
WO2009005258A2 (en) * 2007-06-29 2009-01-08 Mediplex Corp. Heparin conjugates and methods
EP2030624A1 (en) * 2007-08-28 2009-03-04 Johannes Gutenberg Universität Antioxidant and paramagnetic heparin-nitroxide derivatives

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BULPITT P ET AL: "NEW STRATEGY FOR CHEMICAL MODIFICATION OF HYALURONIC ACID: PREPARATION OF FUNCTIONALIZED DERIVATIVES AND THEIR USE IN THE FORMATION OF NOVEL BIOCOMPATIBLE HYDROGELS", JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, WILEY, NEW YORK, NY, US, vol. 47, no. 2, 1 January 1999 (1999-01-01), pages 152 - 169, XP000913609, ISSN: 0021-9304, DOI: DOI:10.1002/(SICI)1097-4636(199911)47:2<152::AID-JBM5>3.0.CO;2-I *
HERSEL U ET AL: "RGD modified polymers: biomaterials for stimulated cell adhesion and beyond", BIOMATERIALS, ELSEVIER SCIENCE PUBLISHERS BV., BARKING, GB, vol. 24, no. 24, 1 November 2003 (2003-11-01), pages 4385 - 4415, XP004446082, ISSN: 0142-9612, DOI: DOI:10.1016/S0142-9612(03)00343-0 *
LUO Y ET AL: "HYALURONIC ACID-N-HYDROXYSUCCINIMIDE: A USEFUL INTERMEDIATE FOR BIOCONJUGATION", BIOCONJUGATE CHEMISTRY, ACS, WASHINGTON, DC, US, vol. 12, 1 January 2001 (2001-01-01), pages 1085 - 1088, XP001222037, ISSN: 1043-1802, DOI: DOI:10.1021/BC015513P *

Also Published As

Publication number Publication date
WO2011018496A2 (en) 2011-02-17
DE102009028526A1 (en) 2011-02-24
EP2464669A2 (en) 2012-06-20

Similar Documents

Publication Publication Date Title
WO2011018496A3 (en) Method for modifying and functionalizing saccharides
WO2009123762A3 (en) Method of screening single cells for the production of biologically active agents
WO2010002152A3 (en) Apparatus and method for correcting errors in a gyro sensor of a mobile robot
DE602007003225D1 (en) METHOD FOR PRODUCING A STARCH HYDROLYZATE
WO2007044763A3 (en) System and method for detecting fraudulent transactions
WO2007133183A3 (en) Polypeptides and biosynthetic pathways for the production of stereoisomers of monatin and their precursors
WO2009114702A3 (en) Recombinant production of authentic human proteins using human cell expression systems
WO2009027752A3 (en) Process for producing hepcidin
WO2009138880A3 (en) Optical sensor apparatus and method of using same
WO2008019123A3 (en) Enzyme sensors, methods for preparing and using such sensors, and methods of detecting protease activity
WO2008119770A9 (en) Method for modifying the structure of a cellulose material by treatment with an ionic liquid
WO2007106459A3 (en) Improved process for the synthesis and methanolysis of ammonia borane and borazine
WO2007117786A3 (en) A process for producing coated urea-formaldehyde polymers
WO2009139930A3 (en) Antibodies and processes for preparing the same
EP2022852B8 (en) Method for production of optically active amine compound, recombinant vector, and transformant carrying the vector
WO2012010974A8 (en) Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystonia
EP2313568A4 (en) Method for forming connecting structure between pillar and beam, and connecting structure between pillar and beam
WO2008076365A3 (en) Analyte sensors, methods for preparing and using such sensors, and methods of detecting analyte activity
WO2007075870A3 (en) Processes for taxane derivatives and intermediates useful therein
WO2007081889A8 (en) Production of dolasetron
WO2013170963A3 (en) Enzymatic synthesis of l-nucleic acids
WO2012085279A3 (en) Method for cross-linking peptides
WO2011033311A3 (en) Improved materials
WO2011153464A3 (en) In situ oriented immobilization of proteins on a support
EP2345077A4 (en) Analyte sensors, testing apparatus and manufacturing methods

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10741975

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2010741975

Country of ref document: EP